Meta-analysis of 17 studies (511 recipients) of HCC beyond Milan downstaged before living donor liver transplant: in the primary cohort recurrence was 22.1% and 5-year survival 75.8%. Downstaging succeeded in 47.5%; evidence is retrospective, mostly Asian.
Meta-analysisn = 511
Jo et al. Post-transplant oncologic outcomes after locoregional downstaging before living donor liver transplantation for hepatocellular carcinoma beyond Milan criteria: a systematic review and meta-analysis of selected cohorts